marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-07-2024
Collegium Pharmaceutical Financial Statements 2011-2024 | COLL
Annual Financial Statements Collegium Pharmaceutical
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
1.05 B | 869 M | 624 M | 831 M | 669 M | 524 M | 733 M | 391 M | 231 M | - | - | - | - |
Shares |
32.3 M | 33.6 M | 34.9 M | 34.4 M | 33.5 M | 33 M | 30.3 M | 24.3 M | 13.5 M | - | - | - | - |
Historical Prices |
32.5 | 25.9 | 17.9 | 24.1 | 20.1 | 16 | 23.8 | 16.8 | 17 | - | - | - | - |
Net Income |
31.9 M | -7.2 M | 71.5 M | 26.8 M | -22.7 M | -39.1 M | -74.9 M | -94.2 M | -27.3 M | -17.9 M | -16.2 M | - | - |
Revenue |
150 M | 130 M | 277 M | 310 M | 297 M | 280 M | 28.5 M | 1.71 M | - | - | - | - | - |
Cost of Revenue |
55.1 M | 79.8 M | 126 M | 130 M | 194 M | 166 M | 2.6 M | 213 K | - | - | - | - | - |
Gross Profit |
94.6 M | 49.8 M | 151 M | 180 M | 103 M | 115 M | 25.9 M | 1.5 M | - | - | - | - | - |
Operating Income |
61.7 M | 11.8 M | 17.6 M | 56.2 M | -23.7 M | -20.7 M | -75.4 M | -94.1 M | -26.9 M | -17.7 M | -16 M | - | - |
Interest Expense |
19.3 M | 20.6 M | 21 M | 28.9 M | 909 K | 20.1 M | 582 K | 94 K | 439 K | 252 K | -155 K | - | - |
EBITDA |
65.2 M | 14.4 M | 19.4 M | 57.1 M | -8.26 M | 90.2 M | -74.9 M | -93.4 M | -26.7 M | -17.5 M | -15.9 M | - | - |
Operating Expenses |
32.9 M | 38 M | 133 M | 124 M | 127 M | 135 M | 101 M | 95.6 M | 26.9 M | - | - | - | - |
General and Administrative Expenses |
32.9 M | 38 M | 119 M | 114 M | - | - | - | - | 18.9 M | 2.71 M | 1.88 M | - | - |
All numbers in USD currency
Quarterly Income Statement Collegium Pharmaceutical
| 2024-Q3 | 2024-Q2 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
32.3 M | 32.4 M | 31.9 M | 33.7 M | 34.6 M | 34.3 M | 33.8 M | 34.1 M | 34 M | 33.7 M | 33.7 M | 35.4 M | 35.3 M | 35 M | 34.6 M | 34.5 M | 34.4 M | 34.1 M | 33.6 M | 33.5 M | 33.4 M | 33.3 M | 33.3 M | 33 M | 33 M | 32.9 M | 32.5 M | 29.8 M | 29.4 M | 29.4 M | 27.1 M | 23.5 M | 23.4 M | 23.1 M | 20.6 M | 20.5 M | 11.8 M | 1 M | 956 K | 941 K | 926 K | 913 K | 963 K | - | - | - | - | - | - | - | - | - | - | - |
Net Income |
9.34 M | 19.6 M | - | 20.6 M | 13 M | -17.4 M | - | 457 K | -5.19 M | -13.1 M | -25 M | 8.05 M | 72.8 M | 15.7 M | 6.96 M | 11.3 M | 8.06 M | 450 K | -2.2 M | -6.11 M | -4.71 M | -9.7 M | 9.09 M | -16.5 M | -13.1 M | -18.7 M | -17.4 M | -13.3 M | -21.1 M | -23.1 M | -27.6 M | -26.4 M | -24.5 M | -15.7 M | -9.52 M | -9.36 M | -4.67 M | -3.69 M | -3.47 M | -6.56 M | -4.12 M | -3.78 M | - | - | - | - | - | - | - | - | - | - | - | - |
Revenue |
159 M | 145 M | - | 137 M | 136 M | 145 M | - | 127 M | 124 M | 83.8 M | 27.4 M | 78.8 M | 82.9 M | 87.7 M | 76.3 M | 79.2 M | 78.1 M | 76.5 M | 74.2 M | 72.9 M | 75 M | 74.5 M | 73.4 M | 70.2 M | 73.1 M | 63.7 M | 10.8 M | 12 M | 3.56 M | 2.17 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
62.5 M | 54.5 M | - | 56.4 M | 61.7 M | 67.4 M | - | 68.2 M | 71.2 M | 35.3 M | 28.7 M | 32.7 M | 32.7 M | 32.1 M | 32 M | 31 M | 29.7 M | 37.5 M | 49.1 M | 46.8 M | 48.7 M | 49.2 M | 29.7 M | 46 M | 46.8 M | 43.1 M | 1.09 M | 553 K | 577 K | 371 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
96.8 M | 90.8 M | - | 80.3 M | 73.8 M | 77.4 M | - | 58.8 M | 52.4 M | 48.5 M | -1.33 M | 46.1 M | 50.2 M | 55.6 M | 44.3 M | 48.2 M | 48.4 M | 39 M | 25.1 M | 26.2 M | 26.4 M | 25.4 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
34.8 M | 47.5 M | - | 45 M | 35.6 M | 24.6 M | - | 20.5 M | 11.1 M | -10 M | -34.1 M | 14.1 M | 16.4 M | 21.2 M | 15 M | 19.6 M | 16.5 M | 5.06 M | -2.37 M | -6.38 M | -5.01 M | -9.99 M | 11 M | -11.2 M | -7.29 M | -13.2 M | -17.6 M | -13.4 M | -21.3 M | -23.2 M | -27.6 M | -26.4 M | -24.5 M | -15.6 M | -9.44 M | -9.26 M | -4.58 M | -3.63 M | -3.33 M | -6.5 M | -4.09 M | -3.74 M | - | - | - | - | - | - | - | - | - | - | - | - |
Interest Expense |
- | - | - | 20.8 M | 21.9 M | 21.4 M | - | 19 M | 17.8 M | 5.83 M | 4.76 M | 5.12 M | 5.42 M | 5.72 M | 7.74 M | 8.06 M | 8.26 M | 4.82 M | 211 K | 228 K | 236 K | 234 K | 2.4 M | 5.87 M | 6.16 M | 5.7 M | 180 K | 167 K | 137 K | 98 K | 20 K | 2 K | 46 K | -66 K | -89 K | 97 K | 99 K | -64 K | -142 K | -51 K | -29 K | -29 K | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
75.6 M | 82 M | - | 81.3 M | 73.1 M | 25.4 M | - | 58 M | 48.6 M | -9.3 M | -17.3 M | 15.5 M | 33.2 M | 21.6 M | 31.8 M | 20.2 M | 16.9 M | 5.26 M | 1.32 M | -5.84 M | -4.65 M | -9.81 M | 11 M | -10.5 M | -6.72 M | -12.7 M | -17.6 M | -13.4 M | -21.2 M | -23 M | -27.6 M | -26.1 M | -24.4 M | -15.5 M | -9.44 M | -9.14 M | -4.48 M | -3.58 M | -3.33 M | -6.36 M | -3.99 M | -3.7 M | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Expenses |
62 M | 43.3 M | - | 35.3 M | 38.2 M | 52.8 M | - | 38.4 M | 41.3 M | 58.5 M | 32.8 M | 32 M | 33.8 M | 34.4 M | 29.3 M | 28.6 M | 31.8 M | 33.9 M | 27.5 M | 32.6 M | 31.4 M | 35.3 M | - | - | - | - | - | - | - | - | 28.9 M | 26.8 M | 24.5 M | 15.6 M | 9.44 M | 9.26 M | 4.58 M | 3.63 M | 3.33 M | 6.5 M | 4.09 M | 3.74 M | - | - | - | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
62 M | 43.3 M | - | 35.3 M | 38.2 M | 52.8 M | - | 38.4 M | 41.3 M | 54.5 M | 26.6 M | 30.5 M | 30.4 M | 31.5 M | 26.8 M | 26.4 M | 29.3 M | 31.3 M | 25.1 M | 30.1 M | 28.9 M | 32.4 M | 30.5 M | 33.4 M | 31.3 M | 31.6 M | 25.1 M | 22.8 M | 22.1 M | 22.8 M | 25.4 M | 23.6 M | 20.2 M | 11.5 M | 7.9 M | 5.91 M | 2.93 M | 2.18 M | 1.02 M | 687 K | 523 K | 475 K | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency